| Date Filed | Type | Description |
| 10/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/12/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/04/2023 |
SC 13G/A
| FIL Ltd reports a 10.8% stake in STRUCTURE THERAPEUTICS INC |
| 09/29/2023 |
8-K
| Quarterly results |
| 09/29/2023 |
8-K
| Quarterly results |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 08/04/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Disposed of 411,000 options to buy
@ $2.6, valued at
$1.1M
Acquired 205,500 options to buy
@ $2.6, valued at
$534.3k
Acquired 205,500 options to buy
@ $2.6, valued at
$534.3k
|
|
| 08/04/2023 |
4
| LOVE TED W (Director) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Granted 75,000 options to buy
@ $0 |
|
| 08/04/2023 |
3
| LOVE TED W (Director) has filed a Form 3 on Structure Therapeutics Inc. |
| 08/04/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 07/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/12/2023 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Disposed of 4,018,253 shares
@ $0
Disposed of 2,929,660 shares
@ $0
Disposed of 462,605 shares
@ $0
Acquired 4,018,253 options to buy
@ $0
Acquired 2,929,660 options to buy
@ $0
Acquired 462,605 options to buy
@ $0 |
|
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 02/13/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/10/2023 |
SC 13G
| FIL Ltd reports a 5.9% stake in STRUCTURE THERAPEUTICS INC |
| 02/10/2023 |
SC 13G
| FMR LLC reports a 8.6% stake in STRUCTURE THERAPEUTICS INC |
| 02/09/2023 |
4
| WELCH DANIEL G (Director) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Converted 123,508 shares
@ $0
Converted 123,508 options to buy
@ $0 |
|
| 02/09/2023 |
4
| Farid Ramy (Director) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Converted 642,245 shares
@ $0
Converted 642,245 options to buy
@ $0
Bought 275,000 options to buy
@ $15, valued at
$4.1M
|
|
| 02/09/2023 |
4
| Jung Melita Sun (Chief Business Officer) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Bought 1,000 options to buy
@ $15, valued at
$15k
|
|
| 02/09/2023 |
4
| Bach Mark Allen (Chief Medical Officer) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Bought 1,500 options to buy
@ $15, valued at
$22.5k
|
|
| 02/09/2023 |
4
| Yoon Jun (CFO) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Bought 600 options to buy
@ $15, valued at
$9k
|
|
| 02/09/2023 |
4
| Stevens Raymond C (CEO) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Bought 4,000 options to buy
@ $15, valued at
$60k
|
|
| 02/09/2023 |
4
| FMR LLC (See Remark 1) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Converted 965,115 shares
@ $0
Converted 57,523 shares
@ $0
Converted 10,154 shares
@ $0
Converted 7,411 shares
@ $0
Converted 6,947 shares
@ $0
Converted 3,572,022 shares
@ $0
Converted 568,098 shares
@ $0
Converted 414,621 shares
@ $0
Converted 214,663 shares
@ $0
Converted 965,115 convertible preferred
@ $0
Converted 57,523 convertible preferred
@ $0 |
|
| 02/09/2023 |
4
| FIL Ltd (See Remark 1) has filed a Form 4 on Structure Therapeutics Inc.|
Txns:
| Converted 4,013,678 shares
@ $0
Converted 620,499 shares
@ $0
Converted 452,867 shares
@ $0
Converted 179,242 shares
@ $0
Converted 71,636 shares
@ $0
Converted 10,154 shares
@ $0
Converted 7,411 shares
@ $0
Converted 494,035 shares
@ $0
Converted 624,239 shares
@ $0
Converted 4,013,678 convertible preferred
@ $0
Converted 620,499 options to buy
@ $0 |
|
| 02/07/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
| 02/06/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
|